Home/StemInov/Julie Hutin

JH

Julie Hutin

CEO & Co-founder

Therapeutic Areas

Inflammatory Diseases Critical Care Infectious Disease

StemInov Pipeline

Drug	Indication	Phase
WhartSep	Severe Pneumonia (leading to septic shock/ARDS)	Phase 1

Leadership Team at StemInov

Danièle Bensoussan

CSO & Co-founder

Clinical Strategy

CMC (Cell Production Expert)

View full StemInov profile